Click here to get full coverage on Is Alkermes (ALKS) Stock Undervalued Right Now? - Yahoo Finance

Is Alkermes (ALKS) Stock Undervalued Right Now?  Yahoo Finance

Is Alkermes (ALKS) Stock Undervalued Right Now? - Yahoo Finance

Click here to get full coverage on Intraday pattern recognizer results for ALKS - Quarterly Earnings Summary & Real-Time Volume Analysis - newser.com

Intraday pattern recognizer results for ALKS - Quarterly Earnings Summary & Real-Time Volume Analysis  newser.com

Intraday pattern recognizer results for ALKS - Quarterly Earnings Summary & Real-Time Volume Analysis - newser.com

Click here to get full coverage on ALKS vs. RGEN: Which Stock Is the Better Value Option? - sharewise.com

ALKS vs. RGEN: Which Stock Is the Better Value Option?  sharewise.com

ALKS vs. RGEN: Which Stock Is the Better Value Option? - sharewise.com

Click here to get full coverage on Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Finance

Are Medical Stocks Lagging Alkermes (ALKS) This Year?  Yahoo Finance

Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Finance

Click here to get full coverage on Intraday pattern recognizer results for ALKS - Gold Moves & Fast Entry Momentum Trade Alerts - newser.com

Intraday pattern recognizer results for ALKS - Gold Moves & Fast Entry Momentum Trade Alerts  newser.com

Intraday pattern recognizer results for ALKS - Gold Moves & Fast Entry Momentum Trade Alerts - newser.com

Click here to get full coverage on Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Nasdaq

Are Medical Stocks Lagging Alkermes (ALKS) This Year?  Nasdaq

Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Nasdaq

Click here to get full coverage on Wall Street Analysts Predict a 34.8% Upside in Alkermes (ALKS): Here's What You Should Know - sharewise.com

Wall Street Analysts Predict a 34.8% Upside in Alkermes (ALKS): Here's What You Should Know  sharewise.com

Wall Street Analysts Predict a 34.8% Upside in Alkermes (ALKS): Here's What You Should Know - sharewise.com

Click here to get full coverage on Intraday pattern recognizer results for ALKS - Trade Signal Summary & Fast Exit and Entry Trade Guides - newser.com

Intraday pattern recognizer results for ALKS - Trade Signal Summary & Fast Exit and Entry Trade Guides  newser.com

Intraday pattern recognizer results for ALKS - Trade Signal Summary & Fast Exit and Entry Trade Guides - newser.com

Click here to get full coverage on Will ALKS stock maintain momentum in 2025 - Earnings Performance Report & Growth-Oriented Investment Plans - newser.com

Will ALKS stock maintain momentum in 2025 - Earnings Performance Report & Growth-Oriented Investment Plans  newser.com

Will ALKS stock maintain momentum in 2025 - Earnings Performance Report & Growth-Oriented Investment Plans - newser.com

Click here to get full coverage on Will ALKS stock continue dividend increases - 2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com

Will ALKS stock continue dividend increases - 2025 Growth vs Value & Fast Gain Stock Trading Tips  newser.com

Will ALKS stock continue dividend increases - 2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com

Click here to get full coverage on How to integrate ALKS into portfolio analysis tools - 2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

How to integrate ALKS into portfolio analysis tools - 2025 Big Picture & Free Daily Entry Point Trade Alerts  newser.com

How to integrate ALKS into portfolio analysis tools - 2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

Click here to get full coverage on Will ALKS stock outperform tech sector in 2025 - Weekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com

Will ALKS stock outperform tech sector in 2025 - Weekly Profit Analysis & AI Optimized Trading Strategy Guides  newser.com

Will ALKS stock outperform tech sector in 2025 - Weekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com

Click here to get full coverage on How to escape a deep drawdown in ALKS - 2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com

How to escape a deep drawdown in ALKS - 2025 Trade Ideas & Scalable Portfolio Growth Ideas  newser.com

How to escape a deep drawdown in ALKS - 2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com

Click here to get full coverage on Using Bollinger Bands to evaluate ALKS - Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com

Using Bollinger Bands to evaluate ALKS - Portfolio Profit Report & AI Based Buy/Sell Signal Reports  newser.com

Using Bollinger Bands to evaluate ALKS - Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com

Click here to get full coverage on How to integrate ALKS into portfolio analysis tools - Weekly Profit Analysis & Weekly Chart Analysis and Trade Guides - newser.com

How to integrate ALKS into portfolio analysis tools - Weekly Profit Analysis & Weekly Chart Analysis and Trade Guides  newser.com

How to integrate ALKS into portfolio analysis tools - Weekly Profit Analysis & Weekly Chart Analysis and Trade Guides - newser.com

Click here to get full coverage on Insider Sale: EVP R&D of $ALKS Sells 9,000 Shares - Quiver Quantitative

Insider Sale: EVP R&D of $ALKS Sells 9,000 Shares  Quiver Quantitative

Insider Sale: EVP R&D of $ALKS Sells 9,000 Shares - Quiver Quantitative

Click here to get full coverage on Intraday pattern recognizer results for ALKS - 2025 Market Sentiment & Daily Price Action Insights - newser.com

Intraday pattern recognizer results for ALKS - 2025 Market Sentiment & Daily Price Action Insights  newser.com

Intraday pattern recognizer results for ALKS - 2025 Market Sentiment & Daily Price Action Insights - newser.com

Click here to get full coverage on Is ALKS a candidate for recovery play - 2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com

Is ALKS a candidate for recovery play - 2025 Institutional Moves & AI Powered Buy and Sell Recommendations  newser.com

Is ALKS a candidate for recovery play - 2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com

Click here to get full coverage on Assessing Alkermes (ALKS) Valuation Following Recent Share Price Momentum - simplywall.st

Assessing Alkermes (ALKS) Valuation Following Recent Share Price Momentum  simplywall.st

Assessing Alkermes (ALKS) Valuation Following Recent Share Price Momentum - simplywall.st

Click here to get full coverage on Interesting ALKS Put And Call Options For December 19th - Nasdaq

Interesting ALKS Put And Call Options For December 19th  Nasdaq

Interesting ALKS Put And Call Options For December 19th - Nasdaq

Click here to get full coverage on Alkermes plc Reports Second Quarter 2025 Financial Results - PR Newswire

Alkermes plc Reports Second Quarter 2025 Financial Results  PR Newswire

Alkermes plc Reports Second Quarter 2025 Financial Results - PR Newswire

Click here to get full coverage on Sector ETF performance correlation with ALKS - 2025 Dividend Review & Short-Term High Return Ideas - newser.com

Sector ETF performance correlation with ALKS - 2025 Dividend Review & Short-Term High Return Ideas  newser.com

Sector ETF performance correlation with ALKS - 2025 Dividend Review & Short-Term High Return Ideas - newser.com

Click here to get full coverage on Orexin Receptor Agent ALKS 2680 Meets End Points in Phase 2 VIBRANCE-1 Study - NeurologyLive

Orexin Receptor Agent ALKS 2680 Meets End Points in Phase 2 VIBRANCE-1 Study  NeurologyLive

Orexin Receptor Agent ALKS 2680 Meets End Points in Phase 2 VIBRANCE-1 Study - NeurologyLive

Click here to get full coverage on Brigita Anna Alks Obituary August 8, 2025 - Lombardo Funeral Home

Brigita Anna Alks Obituary August 8, 2025  Lombardo Funeral Home

Brigita Anna Alks Obituary August 8, 2025 - Lombardo Funeral Home

Click here to get full coverage on Market Catalysts: How risky is ALKS stock now - Trade Analysis Summary & Growth Focused Stock Pick Reports - nchmf.gov.vn

Market Catalysts: How risky is ALKS stock now - Trade Analysis Summary & Growth Focused Stock Pick Reports  nchmf.gov.vn

Market Catalysts: How risky is ALKS stock now - Trade Analysis Summary & Growth Focused Stock Pick Reports - nchmf.gov.vn

Click here to get full coverage on Alkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025 - PR Newswire

Alkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025  PR Newswire

Alkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025 - PR Newswire

Click here to get full coverage on Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia - PR Newswire

Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia  PR Newswire

Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia - PR Newswire

Click here to get full coverage on Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025 - PR Newswire

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025  PR Newswire

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025 - PR Newswire

Click here to get full coverage on Alkermes plc Reports First Quarter 2025 Financial Results - PR Newswire

Alkermes plc Reports First Quarter 2025 Financial Results  PR Newswire

Alkermes plc Reports First Quarter 2025 Financial Results - PR Newswire

Click here to get full coverage on Exit Recap: Is ALKS stock affected by interest rate hikes - July 2025 Action & Smart Money Movement Tracker - nchmf.gov.vn

Exit Recap: Is ALKS stock affected by interest rate hikes - July 2025 Action & Smart Money Movement Tracker  nchmf.gov.vn

Exit Recap: Is ALKS stock affected by interest rate hikes - July 2025 Action & Smart Money Movement Tracker - nchmf.gov.vn

Click here to get full coverage on (ALKS) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

(ALKS) and the Role of Price-Sensitive Allocations  news.stocktradersdaily.com

(ALKS) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Click here to get full coverage on Noteworthy Thursday Option Activity: DASH, ALKS, MDB - Nasdaq

Noteworthy Thursday Option Activity: DASH, ALKS, MDB  Nasdaq

Noteworthy Thursday Option Activity: DASH, ALKS, MDB - Nasdaq

Click here to get full coverage on Using Bollinger Bands to evaluate ALKS - July 2025 Update & AI Powered Market Entry Strategies - newser.com

Using Bollinger Bands to evaluate ALKS - July 2025 Update & AI Powered Market Entry Strategies  newser.com

Using Bollinger Bands to evaluate ALKS - July 2025 Update & AI Powered Market Entry Strategies - newser.com

Click here to get full coverage on Sector ETF performance correlation with ALKS - Earnings Overview Report & Weekly Breakout Watchlists - newser.com

Sector ETF performance correlation with ALKS - Earnings Overview Report & Weekly Breakout Watchlists  newser.com

Sector ETF performance correlation with ALKS - Earnings Overview Report & Weekly Breakout Watchlists - newser.com

Click here to get full coverage on A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $35 to $54 - 富途牛牛

A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $35 to $54  富途牛牛

A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $35 to $54 - 富途牛牛

Click here to get full coverage on Understanding ALKS 2680’s Wake-Promoting Effects Through qEEG: Julia Chapman, PhD - NeurologyLive

Understanding ALKS 2680’s Wake-Promoting Effects Through qEEG: Julia Chapman, PhD  NeurologyLive

Understanding ALKS 2680’s Wake-Promoting Effects Through qEEG: Julia Chapman, PhD - NeurologyLive

Click here to get full coverage on Alkermes (ALKS) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Alkermes (ALKS) Expected to Beat Earnings Estimates: Should You Buy?  Yahoo Finance

Alkermes (ALKS) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Click here to get full coverage on Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - PR Newswire

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference  PR Newswire

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - PR Newswire

Click here to get full coverage on Alkermes (ALKS) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance

Alkermes (ALKS) Tops Q2 Earnings and Revenue Estimates  Yahoo Finance

Alkermes (ALKS) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Vibrance-3: Study Design and Methods for a Phase 2, Randomized, Placebo Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of ALKS 2680 in Patients With Idiopathic Hypersomnia - NeurologyLive

Vibrance-3: Study Design and Methods for a Phase 2, Randomized, Placebo Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of ALKS 2680 in Patients With Idiopathic Hypersomnia  NeurologyLive

Vibrance-3: Study Design and Methods for a Phase 2, Randomized, Placebo Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of ALKS 2680 in Patients With Idiopathic Hypersomnia - NeurologyLive

Click here to get full coverage on Alkermes to Report Third Quarter Financial Results on October 28, 2025 - PA Media

Alkermes to Report Third Quarter Financial Results on October 28, 2025  PA Media

Alkermes to Report Third Quarter Financial Results on October 28, 2025 - PA Media

Click here to get full coverage on ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - Yahoo Finance

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study  Yahoo Finance

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - Yahoo Finance

Click here to get full coverage on Alkermes stock upgraded at RBC Capital Markets (ALKS:NASDAQ) - Seeking Alpha

Alkermes stock upgraded at RBC Capital Markets (ALKS:NASDAQ)  Seeking Alpha

Alkermes stock upgraded at RBC Capital Markets (ALKS:NASDAQ) - Seeking Alpha

Click here to get full coverage on Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia - Yahoo Finance

Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia  Yahoo Finance

Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia - Yahoo Finance

Click here to get full coverage on Those who invested in Alkermes (NASDAQ:ALKS) five years ago are up 79% - Yahoo Finance

Those who invested in Alkermes (NASDAQ:ALKS) five years ago are up 79%  Yahoo Finance

Those who invested in Alkermes (NASDAQ:ALKS) five years ago are up 79% - Yahoo Finance

Click here to get full coverage on Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 - Yahoo Finance

Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025  Yahoo Finance

Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 - Yahoo Finance

Click here to get full coverage on Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - PR Newswire

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences  PR Newswire

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - PR Newswire

Click here to get full coverage on HC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 Study - Yahoo Finance

HC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 Study  Yahoo Finance

HC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 Study - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $ALKS Given $44.0 Price Target - Quiver Quantitative

New Analyst Forecast: $ALKS Given $44.0 Price Target  Quiver Quantitative

New Analyst Forecast: $ALKS Given $44.0 Price Target - Quiver Quantitative

Click here to get full coverage on A Fresh Look at Alkermes (ALKS) Valuation After Wells Fargo's Positive Rating and Q4 2025 Inclusion - simplywall.st

A Fresh Look at Alkermes (ALKS) Valuation After Wells Fargo's Positive Rating and Q4 2025 Inclusion  simplywall.st

A Fresh Look at Alkermes (ALKS) Valuation After Wells Fargo's Positive Rating and Q4 2025 Inclusion - simplywall.st

Click here to get full coverage on Alkermes Plc (ALKS) Stock Analysis: Investor Outlook With A 33.82% Potential Upside - DirectorsTalk Interviews

Alkermes Plc (ALKS) Stock Analysis: Investor Outlook With A 33.82% Potential Upside  DirectorsTalk Interviews

Alkermes Plc (ALKS) Stock Analysis: Investor Outlook With A 33.82% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on How Much Upside is Left in Alkermes (ALKS)? Wall Street Analysts Think 33.19% - Yahoo Finance

How Much Upside is Left in Alkermes (ALKS)? Wall Street Analysts Think 33.19%  Yahoo Finance

How Much Upside is Left in Alkermes (ALKS)? Wall Street Analysts Think 33.19% - Yahoo Finance

Click here to get full coverage on Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025 - PR Newswire

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025  PR Newswire

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025 - PR Newswire

Click here to get full coverage on Brigita Alks Obituary (1942 - 2025) - Buffalo, NY - Buffalo News - legacy.com

Brigita Alks Obituary (1942 - 2025) - Buffalo, NY - Buffalo News  legacy.com

Brigita Alks Obituary (1942 - 2025) - Buffalo, NY - Buffalo News - legacy.com

Click here to get full coverage on Alkermes Appoints Joshua Reed as Chief Financial Officer - PR Newswire

Alkermes Appoints Joshua Reed as Chief Financial Officer  PR Newswire

Alkermes Appoints Joshua Reed as Chief Financial Officer - PR Newswire

Click here to get full coverage on RBC Capital Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $45 - 富途牛牛

RBC Capital Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $45  富途牛牛

RBC Capital Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $45 - 富途牛牛

Click here to get full coverage on New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD) - PR Newswire

New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)  PR Newswire

New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD) - PR Newswire

Click here to get full coverage on Is Alkermes Plc (NASDAQ:ALKS) Trading At A 43% Discount? - 富途牛牛

Is Alkermes Plc (NASDAQ:ALKS) Trading At A 43% Discount?  富途牛牛

Is Alkermes Plc (NASDAQ:ALKS) Trading At A 43% Discount? - 富途牛牛

Click here to get full coverage on Alkermes PLC (ALKS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Debt-Free Milestone - Yahoo Finance

Alkermes PLC (ALKS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Debt-Free Milestone  Yahoo Finance

Alkermes PLC (ALKS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Debt-Free Milestone - Yahoo Finance

Click here to get full coverage on Alkermes to Report Third Quarter Financial Results on October 28, 2025 - The Tech Portal

Alkermes to Report Third Quarter Financial Results on October 28, 2025  The Tech Portal

Alkermes to Report Third Quarter Financial Results on October 28, 2025 - The Tech Portal

Click here to get full coverage on Notable Monday Option Activity: ALKS, BBWI, CVS - Nasdaq

Notable Monday Option Activity: ALKS, BBWI, CVS  Nasdaq

Notable Monday Option Activity: ALKS, BBWI, CVS - Nasdaq

Click here to get full coverage on How Investors May Respond To Alkermes (ALKS) Phase 2 Alixorexton Narcolepsy Trial Outperformance - simplywall.st

How Investors May Respond To Alkermes (ALKS) Phase 2 Alixorexton Narcolepsy Trial Outperformance  simplywall.st

How Investors May Respond To Alkermes (ALKS) Phase 2 Alixorexton Narcolepsy Trial Outperformance - simplywall.st

Click here to get full coverage on Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ... - Yahoo Finance

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ...  Yahoo Finance

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ... - Yahoo Finance

Click here to get full coverage on Alkermes plc (ALKS) reports earnings - qz.com

Alkermes plc (ALKS) reports earnings  qz.com

Alkermes plc (ALKS) reports earnings - qz.com

Click here to get full coverage on ALKERMES Earnings Results: $ALKS Reports Quarterly Earnings - Quiver Quantitative

ALKERMES Earnings Results: $ALKS Reports Quarterly Earnings  Quiver Quantitative

ALKERMES Earnings Results: $ALKS Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program - PR Newswire

Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program  PR Newswire

Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program - PR Newswire

Click here to get full coverage on Alkermes plc (ALKS): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential - Yahoo Finance

Alkermes plc (ALKS): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential  Yahoo Finance

ALKS

Price Chart

Key Statistics

Technicals

About ALKS

Latest News

Is Alkermes (ALKS) Stock Undervalued Right Now? - Yahoo Finance

Intraday pattern recognizer results for ALKS - Quarterly Earnings Summary & Real-Time Volume Analysis - newser.com

ALKS vs. RGEN: Which Stock Is the Better Value Option? - sharewise.com

Advanced Charts

Top Gainers

Top Losers